US Patent 11834513 Antibodies to MUC16 and methods of use thereof
Patent 11834513 was granted and assigned to Memorial Sloan Kettering Cancer Center on December, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+24 properties)
Article (+539 characters)
US Patent 11834513 Antibodies to MUC16 and methods of use thereof
Article
Patent abstract
The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to a polypeptide, or antigenic portion thereof, wherein the polypeptide is selected from a) MUC16 ectodomain polypeptide, b) MUC16 cytoplasmic domain polypeptide, and c) MUC16 extracellular domain polypeptide that contains a cysteine loop polypeptide. The invention's antibodies and compositions containing them are useful in diagnostic and therapeutic applications for diseases in which MUC16 is overexpressed, such as cancer.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
David Spriggs0
Dharmarao Thapi0
Date of Patent
December 5, 2023
0Patent Application Number
169413480
Date Filed
July 28, 2020
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11834513 Antibodies to MUC16 and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.